Scientists have shown that a single 2.5mg dose of vitamin D may be enough to boost the immune system to fight against tuberculosis (TB) and similar bacteria for at least 6 weeks.
Hospitalized patients with community-acquired pneumonia who received treatment regimens against atyical disease-causing pathogens reached clinical stability quicker, had fewer days of hospitalization and had lower mortality rates as a result of their disease, according to a large new study.
Researchers from the Veterans Affairs Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH, evaluated the potentially deadly effects of sleep apnea in patients with heart failure.
Fatigue is one of the most common and distressing symptoms cancer patients experience during chemotherapy and radiation treatment, but it’s difficult for health care professionals to accurately assess its severity.
Spain is below the average European rate for child asthma, according to research undertaken by the International Study of Asthma and Allergies in Childhood (ISAAC).
If you have some form of lung or cardiovascular disease, has your doctor told you how to check today’s “AQI”?and what to do if it’s over 100? Health care professionals should inform sensitive patients about the risks of exposure to air pollutants and recommend avoidance strategies for days when air quality is low, according to a special report in The American Journal of the Medical Sciences, published by the Southern Society for Clinical Investigation by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
The Defense Department is teaming with other federal agencies to prepare the nation to deal with a potential pandemic outbreak of influenza, a senior official said here yesterday.
The U.S. Food and Drug Administration (FDA) cleared for marketing the first respirators that can help reduce the user’s exposure to airborne germs during a public health medical emergency, such as an influenza pandemic.
U.S. and Indian health officials have renewed the Indo-U.S. Vaccine Action Program (VAP), a 20-year-old bilateral collaboration supporting research on vaccines, immunology and related biomedical issues. The VAP aims to reduce the burden of vaccine-preventable diseases of public health significance in India, the United States and other parts of the world, and to promote vaccines as one of the most cost-effective health technologies.
Respiratory syncytial virus (RSV) infection is a widespread infant illness that has been linked to asthma and can be deadly but may be curable by the development of this new vaccine technology by the Sir Albert Sakzewski Virus Research Centre and The University of Queensland’s Faculty of Biological and Chemical Sciences.